Evaluation of the safety and immunogenicity of subcutaneous HX575 epoetin alfa in the treatment of anemia associated with chronic kidney disease in predialysis and dialysis patients

Aim: To assess the safety and immunogenicity of subcutaneous (SC) HX575 (epoetin-α) in dialysis- and nondialysis-dependent adult patients with chronic kidney disease (CKD). Methods: Open-label, single-arm, multicenter study in patients (n = 416) from Germany, Italy, Poland, Romania, Russia, Turkey,...

Descripción completa

Detalles Bibliográficos
Autores principales: Casadevall, Nicole, Dobronravov, Vladimir, Eckardt, Kai-Uwe, Ertürk, Sehsuvar, Martynyuk, Liliya, Schmitt, Susanne, Schaffar, Gregor, Rudy, Anita, Krendyukov, Andriy, Ode, Marité
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dustri-Verlag Dr. Karl Feistle 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5607454/
https://www.ncbi.nlm.nih.gov/pubmed/28766493
http://dx.doi.org/10.5414/CN109159

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5607454/
https://www.ncbi.nlm.nih.gov/pubmed/28766493
http://dx.doi.org/10.5414/CN109159

Ejemplares similares